NO20006547L - Salter av paroxetine - Google Patents

Salter av paroxetine

Info

Publication number
NO20006547L
NO20006547L NO20006547A NO20006547A NO20006547L NO 20006547 L NO20006547 L NO 20006547L NO 20006547 A NO20006547 A NO 20006547A NO 20006547 A NO20006547 A NO 20006547A NO 20006547 L NO20006547 L NO 20006547L
Authority
NO
Norway
Prior art keywords
paroxetine
salts
therapy
processes
preparation
Prior art date
Application number
NO20006547A
Other languages
English (en)
Other versions
NO20006547D0 (no
Inventor
Victor Witold Jacewicz
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20006547D0 publication Critical patent/NO20006547D0/no
Publication of NO20006547L publication Critical patent/NO20006547L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

Piperidin-forbindelser, fremgangsmåter for fremstilling av dem, farmasøytiske preparater omfattende dem og anvendelse av dem i terapi er beskrevet.
NO20006547A 1998-07-02 2000-12-21 Salter av paroxetine NO20006547L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (2)

Publication Number Publication Date
NO20006547D0 NO20006547D0 (no) 2000-12-21
NO20006547L true NO20006547L (no) 2001-02-12

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006547A NO20006547L (no) 1998-07-02 2000-12-21 Salter av paroxetine

Country Status (21)

Country Link
EP (1) EP1091958A1 (no)
JP (1) JP2002519421A (no)
KR (1) KR20010053337A (no)
CN (1) CN1314906A (no)
AP (1) AP2000002017A0 (no)
AU (2) AU4903999A (no)
BG (1) BG105204A (no)
BR (1) BR9911679A (no)
CA (1) CA2336470A1 (no)
CZ (1) CZ20004923A3 (no)
EA (1) EA200100098A1 (no)
GB (1) GB9814316D0 (no)
HU (1) HUP0103712A3 (no)
ID (1) ID27766A (no)
IL (1) IL140385A0 (no)
NO (1) NO20006547L (no)
PL (1) PL345365A1 (no)
SK (1) SK20242000A3 (no)
TR (1) TR200100055T2 (no)
WO (1) WO2000001692A1 (no)
ZA (2) ZA992899B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1622630T3 (da) 2003-05-07 2012-12-17 Osteologix As P009368epdk1
ATE342722T1 (de) 2003-05-07 2006-11-15 Osteologix As Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
PL1732575T3 (pl) 2004-02-26 2011-05-31 Osteologix As Związki zawierające stron do stosowania w zapobieganiu lub leczeniu stanów nekrotycznych kości
CN101010087B (zh) 2004-05-06 2012-06-27 奥斯泰奥洛吉斯公司 用于制备金属有机盐的高收率和快速的合成方法
KR100672184B1 (ko) * 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
ES2745411T3 (es) * 2006-07-27 2020-03-02 Wang Nai Fang Compuestos y composiciones de arilsulfanilo para administración de agentes activos
CN109212055B (zh) * 2018-08-19 2021-05-07 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) * 2018-11-27 2020-10-02 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 一种高稳定性Halo-tag探针及其合成和生物应用
CN116283778B (zh) * 2023-02-23 2025-08-29 江苏理工学院 一种吡唑羧酸类化合物及其制备方法和应用
US20250091996A1 (en) 2023-09-15 2025-03-20 King Faisal University 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
KR100543614B1 (ko) * 1997-06-10 2006-01-20 신톤 비.브이. 4-페닐피페리딘 화합물
KR20010040711A (ko) * 1998-02-06 2001-05-15 피터 기딩스 파록세틴의 염

Also Published As

Publication number Publication date
AU4903999A (en) 2000-01-24
EA200100098A1 (ru) 2001-08-27
HUP0103712A3 (en) 2002-09-30
BG105204A (en) 2001-11-30
HUP0103712A2 (hu) 2002-05-29
CA2336470A1 (en) 2000-01-13
BR9911679A (pt) 2002-01-29
WO2000001692A1 (en) 2000-01-13
AP2000002017A0 (en) 2000-12-31
ZA200100020B (en) 2002-03-25
AU2002100370A4 (en) 2002-06-06
ZA992899B (en) 2000-03-29
ID27766A (id) 2001-04-26
TR200100055T2 (tr) 2001-07-23
SK20242000A3 (sk) 2001-07-10
CZ20004923A3 (cs) 2001-08-15
NO20006547D0 (no) 2000-12-21
KR20010053337A (ko) 2001-06-25
GB9814316D0 (en) 1998-09-02
EP1091958A1 (en) 2001-04-18
CN1314906A (zh) 2001-09-26
PL345365A1 (en) 2001-12-17
IL140385A0 (en) 2002-02-10
JP2002519421A (ja) 2002-07-02

Similar Documents

Publication Publication Date Title
BR0016543A (pt) Novos derivados de piperidina e piperazina
TR200100054T2 (tr) Paroksetin metansülfonat
NO20002787L (no) Nye forbindelser
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
NO20075066L (no) Farmasoytisk sammensetning som inneholder isoflavoner
SE9904505D0 (sv) Novel compounds
NO20006521L (no) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivater
MXPA02011304A (es) Derivados de piperidina farmaceuticamente activos, en partiular como moduladores de la actividad del receptor de la quimocina.
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
SE9900961D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
NO20020282L (no) Nytt difenyl-piperidinderivat
NO20006547L (no) Salter av paroxetine
BR0213994A (pt) Derivados heterocìclicos de glicinamida e seus usos médicos
NO20001934L (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO20026081L (no) Nye forbindelser
SE9802209D0 (sv) Novel compounds
TR199901385T2 (xx) Piperidin t�revleri.
NO982863L (no) Nye forbindelser med analgetisk effekt
DE69813263T2 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
NO20014803L (no) Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem
JO2199B1 (en) Replaced pyrrols
NO20034985L (no) Nye 5-tio-SS-D-xylopyranosid-derivater, fremgangsmåte for fremstilling derav, farmasöytiske blandinger inneholdende dem og den terapeutiskeanvendelse derav
SE9803107D0 (sv) Novel Compunds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application